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Background. Epidemiological evidence continues to accumulate on the eﬀect of psychosocial and behavioral factors in relation to
cancer risk, progression, and mortality. Material and Methods. This article presents the current evidence on the relationship
between psychological stress and the risk of cancer and cellular aging process. Ten databases were searched to identify
publications up to September 2019. References from retrieved articles were also reviewed. We included nine review papers and
26 cohort or case-control studies based on inclusion/exclusion criteria. Results. Results of previously published review articles
did not show consistent evidence for the association between cancer risk and psychological stress, while previous evidence is
stronger regarding the role of chronic psychological stress on cancer growth and metastasis and aging. In seven observational
studies, severe life events, anxiety, depression, insuﬃcient social support perception, or avoiding coping strategy were
signiﬁcantly associated with breast cancer risk. For other speciﬁc types of cancer, 11 studies reported increased risk factors for
stressful life events, and two others found increased mortality or a decline in treatment adherence. Conclusions. Recent
epidemiological evidence generally suggests psychosocial factors may be considered risk factors for speciﬁc types of cancer and
play a key role in the cellular aging process. Understanding molecular mechanisms of the stress interaction is important in
cancer management and prevention. The psychological stressors should be considered when developing or evaluating change in
psychosocial practice.
1. Introduction
The premise that stress-related psychological factors inﬂu-
ence the development or progression of cancer dates back
20 to 30 years of contemporary research [1–3]. Over time,
the association has been widely discussed in the literature
among various professional ﬁelds. Despite an extensive
period of research, the literature ﬁndings are often dispersed
between the ﬁelds [2] largely due to the complexity and mul-
tifactorial etiology of cancer, psychological stress (PS), and
stress-related diseases [4–6]. In vitro studies on animals show
PS can aﬀect all three stages of carcinogenesis. In humans, PS
inﬂuences the main processes in cancer pathogenesis such as
DNA repair, cellular aging, alternations in the immune sys-
tem, and apoptosis [7, 8]. Cancer is among the leading causes
of death globally with 8.2 million deaths in 2012 [9] and 18.1
million new cancer cases and 9.6 million cancer deaths in
2018 for 36 types of cancers with lung, breast, and colorectal
cancers as the most common types [10]. Evidence suggests
5-10% of all cancer risk factors have a genetic predisposi-
tion, and approximately 40-45% are determined by physiol-
ogy, lifestyle (e.g., diet, physical activity, smoking, and
drinking), and environmental risk factors [11]. Up to 20%
of the cancer burden is associated with obesity. Evidence
shows that 33% of lung cancers, 42% of breast cancer (BC),
43% of colon cancer, and 20% of prostate cancers are
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preventable through healthy lifestyle habits and preventive
screening [12]. Psychosocial factors (e.g., mental stress,
adverse life events, long-term depression, and social isola-
tion) can adversely inﬂuence energy balance which contrib-
utes to the development of obesity [13].
The level of biological processes aﬀected by PS
depends on its duration [14]. Short-lasting PS activates
the sympathetic nervous system (SNS) secreting catechol-
amines (CATs), which may exert beneﬁcial eﬀects [15].
In contrast, long-lasting persistent PS or high levels of
PS are accompanied by biological, psychological, and
behavioral changes and may have adverse consequences
on health. Recently, there is growing evidence that depres-
sion is accompanied by increased levels of proinﬂamma-
tory cytokines [16] and is hypothesized as a risk factor
for cancer incidence and survival rates. There is ongoing
debate on whether psychosocial factors should be consid-
ered risk factors for cancer development; until recently,
the results are sparse and ambiguous. Due to increasing
prevalence of cancer disease incidence and mortality as
well as many sources which generate PS, an understanding
the strength of the PS cancer association is important for
the public health.
To our knowledge, the recently published meta-
analyses evaluated the observational ﬁndings published
up to 2017 [16, 17]. Since this time, several new studies
have appeared. In this overview, we present the evidence
on the relationship between PS, depression, and cancer
and important ﬁndings from selected previously conducted
reviews that synthesized this evidence based on observa-
tional studies published earlier. We also present the pro-
posed biological mechanisms linking PS to the onset and
progression of cancer and cellular aging, emphasizing the
possible important role of oxidative stress (OS). We also
identify gaps of the observational studies to provide a
more complete picture of the state of knowledge in this
area of research.
2. Materials and Methods
2.1. Search Strategy. Peer-reviewed research articles were
identiﬁed by applying search strategies using databases:
PubMed, Scopus, ScienceDirect, SpringerLink, Wiley Online,
Taylor & Francis, ArticleFirst, ProQuest, PsycINFO, and
EBSCOhost. A combination of search terms and key words
included Psychological stress (self-reporting stress, psycho-
social stress, major life events, domestic violence, depression,
mental disorders) and cancer or tumor or carcinoma and
outcomes (risk, incidence, mortality) and their combination.
The databases were chosen due to their extensive coverage of
cross-disciplinary and biomedical research scope and objec-
tives. In addition, we hand-searched and cross-tabulated
the reference lists of relevant articles, reviews, and meta-
analysis papers. A comprehensive database search was ﬁnal-
ized in September 2019. We limited the search to literature
published in English.
2.2. Inclusion and Exclusion Criteria. This review included
only the most recent articles reporting observational epide-
miologic studies, systematic reviews, meta-analyses, cohort
studies, and case-control studies that provide new infor-
mation on the association between PS among diﬀerent
types of cancer survivors. Other article types such as con-
ference abstracts, short communications, commentaries,
editorials, brief reports, position papers, and hypothesis-
generating statements were excluded based on lack of sci-
entiﬁc merit. Only studies published in peer-reviewed
journals were included. Inclusion criteria for this paper
were physician-diagnosed cancer, given PS measurement
tools, provided information on cancer type and association
between PS and cancer type or overall cancers. We
included case-control studies when odds ratio (OR) with
95% conﬁdence interval (CI) or P value for statistical sig-
niﬁcance and numbers of cases and controls for each spe-
ciﬁc cancer site and type of psychosocial factors measured
and matched or adjusted for age. Cohort studies were
included if they reported relative risk (RR) or hazard ratio
(HR) estimates and incident cases and subject (person-
year) or they reported the number of cases and controls,
and risk estimates were adjusted for confounding.
2.3. Study Selection. We selected original human studies:
case-control studies, hospital-based case-control studies,
prospective cohort studies, and prospective cross-sectional
studies, which reported estimates of the relationship between
self-reported psychosocial stressors, depression, and cancer
risk. Outcomes included cancer risk for the following speciﬁc
cancer sites: breast, brain, pancreas, colon, rectum, stomach,
prostate, lung, cervical, bladder, the central nervous system,
and white blood system (leukemia).
When considering multiple articles on the same popula-
tion, the article based on longer follow-up intervals and con-
tained more data was selected for consideration. Finally, 35
studies (26 observational studies and 9 review articles) were
included in this review.
2.4. Data Extraction. Two research staﬀ members (J.B. and
M.G.) independently screened the titles and abstracts and
evaluated the full-text articles. In the case of any disagree-
ments regarding article inclusion, the problem was resolved
through discussion with a third member of research staﬀ
(J.K.). Details on the type of study, study design, authors,
publication journal and year, country where the study was
carried out, study design, participant characteristics, speciﬁc
outcomes, components of PS assessment and measurement
tool, subtype of cancer, number of cases, number of con-
trols, follow-up period, eﬀect size, estimates of relationships
and their measure with 95% CI or P value, variables of
adjustment, statistical methods, and discussion of the study
limitation were extracted. Only those articles reporting or
assessing risk for cancer disease associated with PS and
depression and reporting eﬀect size and 95% CI based on
suﬃciently large samples were included in this review. Both
case-control and cohort studies included in this paper
showed key elements of study design, provided eligibility
criteria, clearly deﬁned outcomes (type or subtype of cancer
and components of PS), had the representative numbers of
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cases and controls, and reported eﬀect size adjusted for
potential confounders.
3. Results
During the search of ten electronic databases (Figure 1), a
total 1,700 titles were identiﬁed.
After screening the titles and abstracts, 1,233 studies were
excluded on association merit, 209 were excluded as dupli-
cate studies, and 223 were excluded after review as the data
did not meet inclusion criteria. Thus, observational stud-
ies—14 cohort studies and 12 case control studies linking
PS with cancer—were analyzed in this review. In addition,
the ﬁndings of nine review and meta-analysis studies were
discussed. The studies were performed in diﬀerent conti-
nents: America, Asia, and Europe.
3.1. Reviews and Meta-analysis Finding. Epidemiological
research on this topic was a subject of a number of reviews,
including those recently published by Chida et al. [18],
Schraub et al. [19], Moreno-Smith et al. [20], Antonova
et al. [1], Heikkilä et al. [21], Denaro et al. [2], Jia et al.
[16], Chirac et al. [22], and Yang et al. [17] which reviewed
studies published between 1940 and 2017.
The previous meta-analysis study by Chida et al. [18]
investigated the association between stress-related psychoso-
cial factors and cancer risk. The authors found PS was signif-
icantly associated with increased lung cancer incidence
among initially healthy individuals; shortened survival time
in patients with breast, lung, head and neck, hepatobiliary,
and lymphoid cancers; and higher cancer mortality; however,
the magnitudes of HRs appeared to be very small. Although
the authors’ ﬁndings were based on a large number of the
observational studies (165) and calculated HRs were
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Figure 1: Flow diagram of literature search process.
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statistically signiﬁcant, the meta-analysis study combined
data from studies with diﬀerent variables (e.g., clinical out-
come, treatment, population, measurement methods, control
for confounding for lifestyle factors for a particular subtype
of cancer, and what can inﬂuence eﬀect estimates). Thus,
the study provided evidence of a low positive association
between stress-related psychosocial factors and cancer.
Schraub et al. [19] reviewed 32 studies on the relationship
between life-event stress, depression, and the risk of several
types of cancers mainly BC, published between 1940 and
2004. The included eighteen studies showed no association
between PS factors and cancer risk, and six studies found a
signiﬁcant association in one or several subgroups. The
authors estimated PS may increase BC risk, although four
of nine studies presented no signiﬁcant increase, and one
study showed a decrease in risk. Majority of the 11 studies
noted no signiﬁcant association between stressful life events
and overall cancer risk. For speciﬁc cancers (leukemia, lym-
phoma, melanoma, colon, and cervix), more than a 20%
increase in cancer risk was reported. In addition, a 65%
increase in the risk for tobacco-related cancers and signiﬁ-
cantly decreased risk of endometrium cancer (33%) in users
of hormone replacement therapy (HRT) and among normal
weight women (37%) were noted. Also, a 40% decreased risk
of colorectal cancer occurred within the female subgroup for
moderate intensity of PS. Findings were controversial for
relationships between depression or personality and risk for
cancer. The authors found a 38% increase in cancer incidence
and 20-96% increase in mortality among individuals suﬀer-
ing from depression (in two of seven studies) and a 20%
decrease in the risk (in one study). Only one of the six studies
presented a signiﬁcant increase in cancer risk when personal-
ity was a factor. It is noteworthy that Schraub et al. [19] ana-
lyzed only cohort studies and case-control in population
cohort, but not the classical case-control studies to minima-
lize the inﬂuence of selection bias and recall bias. The authors
suggested no conclusions regarding life events or depression
and cancer development or progression can be drawn.
Antonova et al. [1] reviewed 16 studies published between
2000 and 2010 focusing on associations between diﬀerent
types of stress-related events (work-related stressors, daily
stress, and war- and conﬂict-related exposures) and BC inci-
dence. The authors noticed inconsistencies in the ﬁndings,
e.g., a strong causal link between high job demand, job strain,
or severe life events (divorce, separation, or death of husband,
child, or a close relative) and BC risk (HR ranged between 1.12
(1.0-1.25) and 2.65 (1.06-6.60)) reported in several studies and
lower risk associated with high intensity stress HR: 0.60 (0.37-
0.97) shown in other studies. The authors concluded the stress
hormone cortisol may increase the rate of BC growth and the
PS-cancer risk association was strongly dependent on the type
of stress and on stress timing, particularly, for the stress
induced bymajor life events, e.g., maternal death in childhood.
A meta-analysis performed by Heikkilä et al. [21] of data
from 12 prospective European cohort studies (116,056 indi-
viduals aged 17-70 free from cancer at baseline with a
follow-up period 1985-2008; 5,765 all cancer cases: 522 colo-
rectal, 374 lung, 1,010 BC, and 865 prostate cancer (PCa)
identiﬁed) on work stress and high job strain reported multi-
variable adjusted HR: 0.97 (0.90-1.04) for overall risk of can-
cer and also nonsigniﬁcant risks for the speciﬁc cancers.
Denaro et al. [2] reviewed seven observational studies pub-
lished between 1995 and 2009, including one meta-analysis
study. The ﬁndings of the meta-analysis did not conﬁrm an
overall relationship between PS-related life events and BC risk,
although the data reported a modest correlation for death of
spouse. Four reviewed studies observed a positive correlation
between life events and BC, HR, or OR ranged from 1.12
(1.0-1.25) to 3.70 (2.61-5.26), but two studies were not con-
trolled for confounding factors. The authors concluded epide-
miologic evidence provides a strong support for a positive
correlation between PS and BC risk, but variables determining
the stress-cancer link were numerous and diﬃcult to verify.
Further, the recently published systemic review by Chirac
et al. [22] including all studies from 1966 to 2016 (52 eligible
studies) on the eﬀect of PS on BC found positive associations
between experience of stressful events, personal traits, and
BC in 26 observational studies, negative correlations in 18
studies, and data in eight studies could not be classiﬁed. Their
qualitative analysis suggested a possible association between
stressful life events and cancer; however, they highlight the
methodological heterogeneity within the studies.
In turn, Moreno-Smith et al. [20] reviewed the associa-
tion between psychosocial factors, mainly chronic stress,
and cancer progression, focusing on biological processes
aﬀected by chronic PS. The authors found strong evidence
for the eﬀect of chronic stress, depression, and social isolation
on cancer progression and limited evidence for the role of
behavioral factors in cancer initiation.
The recent systematic review and meta-analysis con-
ducted on January 1, 2017 of 25 studies published during
1988-2015 by Jia et al. [16] on the association between
depression and incident of risk for breast, colorectal,
colon, liver, lung, and prostate cancers found depression
signiﬁcantly increased RR of overall cancers by 15%, liver
cancer by 20%, and lung cancer by 33%. The authors
noticed no signiﬁcant association for BC, PCa, or colorec-
tal/colon cancer and increased risk of overall cancer
among North America individuals.
Another meta-analysis of observational studies of Yang
et al. [17] on the association of work stress and cancer risk
included nine studies (281,290 participants, 9,090 incident
cases) published during 2004-2017. The authors found statis-
tically signiﬁcant eﬀects of work stress on an increase of the
risk of several types of cancer: colorectal, RR = 1:36 (1.16-
1.59); lung, RR = 1:24 (1.02-1.49); esophagus, RR = 2:12
(1.30-3.47), but not on prostate, breast, or ovarian cancers.
However, the authors found the eﬀect of work stress on colo-
rectal cancer risk was signiﬁcant only among participants
from North America and increased risk was high (50%),
but the association was not signiﬁcant among participants
from Europe. On the contrary, the eﬀect of work stress on
esophagus cancer risk was found to be signiﬁcant in Europe,
but not in North America.
3.2. Observational Studies. A summary of the evidence relat-
ing PS to BC risk from observational studies published dur-
ing 2011-2018 is shown in Table 1.
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A hospital-based case-control study by Kruk [23]
included a large sample size of women with histopathological
conﬁrmation of the cancer (n = 1,943). Participants were
characterized by detailed information on potential con-
founders using a self-administrated structured questionnaire,
and the risks of BC were estimated in multivariate analysis
and tests for linear dose response was conducted. Several
major life events, like death of a close family member, per-
sonal injury, illness, troubles with the law, or retirement, were
statistically signiﬁcant in their association with BC risk; the
increased risk ranged from 1.58 to 2.94. Additional analysis
showed signiﬁcantly increased risks for two periods of PS
events—lifetime and beginning at birth—and ending 5 years
before the cancer diagnosis, for life score levels > 70, being
the highest for scores > 210. Life events’ scores were esti-
mated based on the Holmes and Rahe social readjustment
rating scale [33]. The highest mean weight on this scale is
100 scores (death of husband); divorce was scored at 73
points, separation at 65 points, and death of a close family
member at 63 points.
Wang et al.’s [24] case-control study identiﬁed the associ-
ation of PS alone and combined lifestyle determinants are con-
sidered potential risk factors (low physical activity, alcohol
intake, cigarette smoking, diet rich in animal meat, and high
intake of fried food) with BC risk. After adjusting for known
risk factors, the authors noted a 65% increase in risk for high
perceived PS; ORs ranged from 1.89 to 3.36 when perceived
stress was combined with these risky lifestyle behaviors.
Li et al. [25] used a comparative case-control study of 582
women with benign BC and 540 controls, aged ≤40 years
showing that frequent depression, negative emotion (e.g.,
fear, worries, nervousness, sorrow, and helplessness), and
disharmonious marital status were associated with the devel-
opment of early onset BC.
Sawada et al. [26] analyzed data from 29,098 women
from 23 study areas throughout Japan to ﬁnd the relationship
between BC incidence and psychological traits. PS was evalu-
ated using subjects’ response to questions: having “ikigai”,
i.e., “something that makes one’s life worth living”, decisive-
ness, ease of anger, and perceived stress of daily life with 3- or
4-point Likert-type response (disagree, neither, agree, and
agree strongly). They found that none of the psychological
traits were signiﬁcantly associated with BC risk. However,
this study has important limitations noted by the authors,
i.e., 1-item measures of stress which could attenuate the true
relationship between BC incidence and each item.
In turn, a prospective cohort study by Schoemaker et al.
[27] comprising a large sample of women aged ≥16 and
focusing on BC etiology used a postal questionnaire of which
a follow up was repeated every 2.5-3 years to update risk
factor information and obtain data on BC diagnosis.
Researchers identiﬁed 1,510 cases with invasive cancer and
273 with in situ cancer during an average follow-up period
of 6.1 years. The study tested a wide range of PS variables
and carried out analyses by estrogen-receptor status, includ-
ing BC risk factors (physical activity, obesity, alcohol intake,
and smoking). This study observed no association between
adverse life events, evaluated as the highest score in the
Holmes and Rahe scale, and cancer, except a 31% increased
BC risk among a subgroup of women under 20 years who
experienced maternal death. However, the risk was not ele-
vated when their mother had BC or ovarian cancer.
Yeh and Lee [28] analyzed data from a medical center’s
outpatient department in Taiwan whose patients were sched-
uled to receive mammography screening. The authors
grouped participants into cases and controls based on patho-
logical biopsy results. The Perceived Stress Scale measured
general, life, and work-related stress perception. The Hospi-
tal Anxiety and Depression Screens for symptoms of anxiety
and depression combined were applied. Participants com-
pleted demographic, lifestyle, and medical history basic char-
acteristic questionnaires. The results showed participants
with borderline anxiety were approximately 3 times more
likely to have BC compared to subjects with no anxiety; sub-
jects with depression had 4.5 times higher BC risk than sub-
jects with no depression. The authors estimated that every
point added to the average total stress score increased BC risk
by 1.124 times concluding that stress, anxiety, and depression
may be predictors of BC risk.
The Özkan et al.’s [29] case-control study analyzed the
association between PS and social support with BC risk using
the Stress Assessment Form and the Coping Strategy Indica-
tor. The ﬁrst form included data on childhood trauma (e.g.,
death of mother, death of father, and divorced parents) and
major life events (e.g., death of husband, divorce, and a
chronic serious disease). The second form contained 33 items
for an evaluation of brief coping inventory. The results
showed the increase in BC risk may be related to general life
stress, such as existence of a stressor experience, perception
of inadequate social support, or use of avoidance social sup-
port coping strategies.
The recent prospective cohort study by Butow et al. [30]
was comprised of Australasian women aged 18-75 on the
relationship between life-event stressors, social support, per-
sonality, and risk of developing BC among women with his-
tory of increased familial of BC. The authors applied
semistructured phone interview, the Life Events and Diﬃcul-
ties Schedule interview protocol, and other questionnaires to
estimate social support, optimism, and antiemotionality to
obtain data on acute or chronic severity, e.g., death of a spou-
se/child, handicapped child requiring full-time care, and
moderate stress such as buying/selling a home. The authors
also identiﬁed eight psychosocial variables as predictors or
moderators of the eﬀect of stress on BC development, e.g.,
social support, personality, acute chronic stressors, and opti-
mism. The authors did not report signiﬁcant associations
between any life-event stressors independently on its inten-
sity in unadjusted and adjusted models.
Fisher et al.’s [31] case-control study of women aged
24-75 years identiﬁed evidence for life events perceived
as stressful (abortion, illness, and relocation) and non-
stressful (death of sibling, illness, and illness in family)
considered as potential risk factors for BC. After adjust-
ment for known risk factors for BC development, the
authors found a cumulation of adverse life events per-
ceived as stressful was signiﬁcantly linked with increased
risk for BC in a dose-response manner (OR = 1:63 (1.00-
2.66), P trend = 0:045) and those life events perceived as
7Oxidative Medicine and Cellular Longevity
nonstressful did not show statistical signiﬁcance in the PS-
cancer relationship. Further, regardless of personal illness
perception (stressful or nonstressful), previous illness
increased BC risk (OR = 2:84 (1.96-4.11), OR = 3:47
(1.34-8.94), respectively). Also, regardless menopausal sta-
tus, nulliparous women or who had their ﬁrst child at
≥30 years of age had increased BC risk.
Yildirim et al. [32] used a hospital-based case-control
study of 250 cases treated for BC (surgery, chemotherapy,
and radiotherapy), aged 27-64 years, to estimate PS inﬂuence
on BC risk, applying semistructured interview, the Stress
Evaluation Form, and the Healthy Lifestyle Behavior Scale.
Lifelong stressful events such as childhood trauma (e.g., loss
of mother or father, divorce of parents, or serious health
problems), major life events (death of a loved one, serious
disease, and divorce), chronic stressor (e.g., interpersonal
relationship problems), and experience of stress within the
last ﬁve years before disease were collected. The authors
found that loss of father during childhood increased BC risk
2.68 times, inadequate social support 1.83 times, and serious
stressor within the last ﬁve years 4.72 times. Also, psychiatric
history was a factor increasing BC risk (1.95-fold). The
authors underlined the particularly important inﬂuence of
stressful events within the last ﬁve years on BC development.
A summary of the evidence linking PS to cancer other
than BC is given in Table 2.
A hospital-based case-control study by Cabaniols et al.
[34] included patients aged 18 and older with previously
untreated glioma grades II-IV. The authors found a 90% sig-
niﬁcant increase in the risk of malignant primitive brain can-
cer caused by major PS life events and insigniﬁcant decreased
risks related to daily stress OR: 0.90 (0.49-1.71) and to stress
at work OR: 0.69 (0.27-1.74), measured over ﬁve years before
cancer diagnosis. The authors suggest genetic factors are
involved in glioma cancer and unexpected acute PS may par-
ticipate in malignant primitive brain tumor development.
The Huang et al. [35] study was a large nested case-
control study that included the Swedish population and
health registers, which examined whether the death of a
child was linked with pancreatic cancer in men and
women aged 55 years and older. The authors noted a
9% increase in the risk associated with the death of child
(overall). The risk increment to 27% was observed within
the ﬁrst ﬁve years after a child’s death and also for loss
of a child due to suicide (23%). The PS-pancreatic cancer
association was only statistically signiﬁcant in women (a 37%
increase in the risk compared to controls) and in men with
psychiatric illness, OR = 2:1 (1.52-2.91). In addition, the
authors found participants with a history of psychiatric dis-
ease experienced increased pancreatic cancer risk to the
greatest extent after child loss.
The Vasunilashorn et al. [36] study included a cohort of
Taiwanese adults aged above 53 years and characterized the
association between perceived stress based on six items deal-
ing with the respondents’ and their family health, ﬁnancial
situation and occupation, and mortality risk during the 11-
year follow-up period. The authors found perceived stress
caused a 19% statistically signiﬁcant increase in mortality risk
only among individuals with poor health outcomes. The
authors concluded the observed relationship between per-
ceived stress and mortality may be dependent on a partici-
pant’s current health.
The large follow-up study conducted byMomen et al. [37]
used data from Danish and Swedish national registers study-
ing the association between bereavement by the death of a
close relative before 15 years of age as an indicator of severe
PS and childhood leukemia cancer. The authors found an
approximate 10% increase in the risk of all childhood cancers
and a 14% increase for central nervous system tumors due to
bereavement. They concluded that experience of PS in early
life is linked with a small elevated risk of childhood cancer risk.
The Azizi and Esmaeili [38] case-control study con-
ducted in four Iranian hospitals identiﬁed the relationship
between stressful life events assessed using the Holmes and
Rahe Life Events Questionnaire and colorectal cancer. After
adjusting for known risk factors, the authors found 2.49
times higher risk of colorectal cancer linked with the death
of loved ones compared with controls. Authors found stress-
ful life events with lower weight on the Holmes and Rahe
scale such as family disputes and job problems, and serious
ﬁnancial problems also increased risk, but without statistical
signiﬁcance. The authors suggest stressful life events may be a
factor increasing risk of colorectal cancer.
Kikuchi et al. [39] analyzed data from 61,563 participants
from the Japan Collaborative Cohort Study to measure the
relationship between perceived stress estimated on a 4-
point Likert scale and colorectal cancer incidence. The
authors found a signiﬁcant relationship between daily per-
ceived stress of moderate or high/severe intensity and rectal
cancer incidence, e.g., 2.16-fold and 1.75-fold increases in
the risk among men, respectively, but not for colon cancer
incidence. The higher HR for cancer incidence was observed
in women at the moderate stress level than at the high/severe
stress level, indicating a reverse U-shaped relationship. Due
to wide 95% CI of the HRs rectal cancer and a lack of statis-
tical signiﬁcance for colon cancer, the authors recommend
further research with a greater sample size.
The Blanc-Lapierre et al. [40] population-based case-
control study analyzed the association between perceived
workplace PS over the entire work career and cancer among
men. The authors observed that employment in at least one
stressful job (e.g., high demand, time pressure, ﬁnancial
issues, and job insecurity) was signiﬁcantly linked with
increased ORs of cancer at 5 of 11 sites, i.e., the lung, colon,
bladder, rectal, and stomach with a duration trend. Nonsig-
niﬁcant increases in risk of cancer of the non-Hodgkin lym-
phoma, kidney, melanoma, pancreas, and esophagus were
also noted. Short-term (<15 years) work-related stress was
not linked with any cancer. Contrary, signiﬁcant associations
were noted for longer cumulative periods of exposure to per-
ceived job stress (15-30 years or above 30 years) and the lung,
colon, bladder, rectum, stomach, and non-Hodgkin lym-
phoma cancers, and borderline signiﬁcant risk for prostate
cancer. The authors recommend further studies with detailed
assessment of all job stressors during employment carried
out on larger case and control groups.
Kim et al. [41] examined the prevalence and prognostic
signiﬁcance of psychological distress (PD) in gastric cancer
8 Oxidative Medicine and Cellular Longevity
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patients. The authors used three methods to measure the
severity of anxiety, insomnia, and depression, and the degree
of functional impairment. The data showed 33.6% of partic-
ipants were identiﬁed as patients with PD. The patients with
PD had worse disease-free survival rates compared with
patients without PD. In stage IV of cancer, patients exhibited
almost 2.5-times poorer overall survival rates than patients
without PD, HR = 2:47 (1.07-5.68). The authors demon-
strated that patients with gastric cancer, independent of can-
cer stage, experienced PD due to worse survival outcomes
and recommend further studies on the role of psychothera-
peutic intervention on improved patient survival outcomes.
A large cohort study by Chang et al. [42] on the role of
depression in overall cancer and hormone-related cancer
development in the general population (aged 30-60 years)
observed diﬀerences in direction and magnitude among rela-
tionships in men and women for cervical cancer. Authors
identiﬁed at baseline major depression in 7.4% men and
10.2% women. Major depression caused a 5% increase of
total cancer in men and a 10% decrease in women. In turn,
minor depression identiﬁed at baseline in 19.3% men and
21.4% women resulted in a 3% increase of the total cancer
risk in men and was without eﬀect among women. The
authors suggested a lack of the association between depres-
sion and cervical cancer and BC development; however, a
13% increase of PCa risk in men aﬀected by minor depres-
sion was observed. According to the authors suggestion, the
depression-cancer association would beneﬁt from future
studies that consider speciﬁc cancer subtypes and mecha-
nism interaction.
In turn, a large international study based on data from 19
countries by O’Neill et al. [43] reported the association
between a number of retrospectively assessed lifetime preva-
lence of 16 DSM-IV mental disorders (anxiety disorders,
mood disorders, substance use disorders, and impulse con-
trol), major depressive dysthymia, and risk of overall cancer.
These authors found the positive association between a num-
ber of mental disorders (OR ranging from 1.3 to 2.3) and
overall cancer risk; the magnitude of the relationship was
higher in women, and the possible carcinogenic impact of
mental disorders was diﬀerent in various periods of respon-
dent’s life. Signiﬁcant eﬀects of depression were observed
with cancer diagnosis in a subgroup of women up to age 44
and were strongly linked with cancers diagnosed early in
respondents’ life as well as in women. O’Neill et al. [43]
maintain that early diagnosis and treatment of mental disor-
ders is important to avoid the increased risk of cancer occur-
rence caused by inferior lifestyle characteristics.
The Archer et al. [44] prospective cohort study
(Whitehall II, all London-based oﬃce staﬀ) of 17.4 years
follow-up time analyzed the relationship between chronic
depressive symptoms and smoking-related (109 cases),
hormone-related (311 cases), and other cancers (356 cases)
using the General Health Questionnaire depression sub-
scale among participants aged 35-55 years at baseline.
The authors stated chronic depression was not associated
with overall cancer incidence when estimated for signiﬁ-
cant years of follow-up time. However, the authors found
signiﬁcantly increased risk (89%) among patients who
experienced a new episode of mental disorder in the ﬁrst
9 years of follow-up time. In the authors’ opinion, subclin-
ical cancer diagnosis can directly aﬀect the brain and elicit
sickness behaviors and depressive symptoms.
Li et al. [45] carried out a case-control study nested in
Shanghai city with 250 PCa cases and 500 controls, which
examined whether psychosocial factors including occupa-
tion, marital separation, and suﬀering predisposed men to
PCa risk. After adjustment for confounding hormone-
related factors (lifestyle, eating habits), men who presented
a high level of stress caused by negative psychosocial factors
had signiﬁcantly increased risk; RRs ranged from 1.61 for
occupational factors to 2.37 for sensitivity to personal com-
ments. Marital separation also exhibited a high magnitude
of PCa risk increase (1.94-fold). In addition, the authors
found decreased PCa risk with regular intake of green vegeta-
bles and green tea, increased risk with alcohol, red meat, and
processed food consumption.
Song et al. [46] explored the associationbetweenperceived
stress levels (baseline and updated after a 5-year follow-up
period) and overall cancer risk (gastric, esophageal, colon,
lung, prostate, breast, liver, rectal, and pancreatic). The
authors used self-reported data from the Japan Public
Center-based Prospective Study which enrolled 140,420 par-
ticipants aged 40-69 years. Among them, 101,708 individuals
declared perceived stress. Increased risk for overall cancers
by 11% was observed among all participants that experienced
consistent high intensity PS (P − trend = 0:0002), by a 19% in
men (P − trend = 0:0001) and by a 7% nonsigniﬁcant risk in
women (P − trend = 0:1227) compared to those reporting
constantly low stress levels. In separate analyses, cancer risk
was signiﬁcantly increased in men and was especially high
among smokers, alcohol drinkers, obese, and those without
family history of cancer. Using analysis by type of cancer, the
authors reported the highest sensitivity to PS stress was
observed for liver cancer (33%), PCa (28%), and pancreatic
cancers (26%).
Using a large case-control study, Blanc-Lapierre et al.
[47] analyzed the association between perceived lifetime
workplace stress and newly diagnosed PCa risk. Individ-
uals answered questions to determine whether their job
made them feel tense, anxious, or stressful most of the
time. There was a dose-response increased PCa risk across
stress duration categories. 58% of respondents recognized
that at least one job was stressful during their professional
career. The risk was increased among men aged ≤65 who
reported more than 30 years of workplace stress by 12%
per 10-year increment for both low-grade and high-grade
PCa. The researchers concluded that PS was reported
more often in white-collar jobs and was signiﬁcantly
linked to PCa diagnosed at a younger age.
Based on a large cohort sample (n=6571) of cancer-free
women from the Danish Nurse Cohort aged 45-70 years at
inclusion, Vesterlund et al. [48] analyzed the association
between prolonged job strain, measured using single items
dealing work speed or load, the number of duties entrusted,
and level of participants’ ordinary eﬀect on organization of
duties during working time across six years and cancer risk
(overall cancer, virus immune-related, hormone related,
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digestive, and the lung) based on self-reported questionnaires
on job strain. The authors noted a high percentage of cancer
cases with perceived PS, but no evidence of an increased
risk of any cancer subtype among the examined group
due to prolonged job strain. We suggest that too small
numbers of respondents declaring high job-strain level
(n = 692 compared with those declaring low job-strain
level, n = 4,155) might also aﬀect the results. Although,
as the authors emphasize, the eﬀect of job strain may dif-
fer between men and women and being dependent on sev-
eral factors including lifestyle.
The Jafri et al. [49] study estimated the eﬀect of major
stressful life events on developing lung cancer using the
Holmes and Rahe Life Event Questionnaire. The study was
a case-control study matched for age, sex, and smoking status
(but not for the duration of smoking exposure) with patients’
median age of 64.1 years. The percentage of diabetes among
controls was signiﬁcantly higher than cases as well as diabetes
and β-blockers users. The examined groups did not diﬀer in a
number of experienced stressors during lifetime, but there
was signiﬁcant diﬀerence in a number of major stressful
events experienced in the preceding 5 years (higher among
cases). The authors found an approximate 2.2-fold increase
in the risk of lung cancer, due to stressful events experience
within the preceding 5 years. Additionally, the authors
observed that use of β-blockers may prevent against lung
cancer development.
4. Discussion
This article summarizes the current information in a con-
densed form on behavioral factors, such as chronic PS,
depression, mental disorders, exposure to job stress, and
social isolation on the development and progression of
cancer, and role of the stress in the cellular aging. We also
provide current insights into some plausible biological
mechanisms based on previously published reviews and
meta-analyses and achievements in the last years. We also
highlighted the complexity of this relationship and
attempted to explain the contrasting ﬁndings between
observational studies. The large number of epidemiological
researchers reporting relationships between psychosocial
and behavioral factors and cancer risk demonstrates the
importance of PS in public health and cancer therapy.
This update of the epidemiological evidence is based on
analysis of nine previously published reviews of 225
worldwide ﬁndings and 26 cohort or case-control studies
that did not show major biases a priori. Considering
review articles for severe life events and BC, increased risk
was concluded in ﬁve [1, 2, 17, 20, 22] of nine reviews. In
addition, two of the nine reviews concluded a signiﬁcant
positive relationship between depression and social isola-
tion and cancer progression [16, 20] although one review
[34] reported controversial ﬁndings for depression where
PS appeared to have a protective eﬀect for colon and
endometrial cancers. One review study [18] reported
stress-related psychosocial factors could slightly shorten
survival time in patients with diagnosis of BC as well as
increase cancer mortality.
In the relationship between stressful life events and
occurrence of other cancer types, the inconsistency of the
epidemiologic studies reviewed and equivocal ﬁndings of a
dose-response association lead us to conclude no signiﬁcant
relationship, with the exception of the positive association
with cervix and colon cancers [21], colorectal (only in North
America), esophagus and lung cancers [17, 18, 49] or endo-
metrial and colorectal cancers, where stress occurred as a
protective factor [19]. Two review papers highlighted the sig-
niﬁcance of chronic stress, social isolation, and depression on
cancer progression, but limited evidence in cancer initiation
[16, 20], and one review [19] maintained PS may shorten sur-
vival time in a few cancer subtype of patients. This issue
might introduce selection bias because the relationship was
weak; the authors do not rule out causal linkage.
Psychological stress at work is considered by the Ameri-
can Institute of Stress [50] as the most frequent type of stress.
Job stress is characterized by high demands (“excessive work-
load and the need to work fast”) and degree of control (“low
decision latitude”) [48]. Five of nine review papers studied
associations between PS at work and overall cancer or spe-
ciﬁc types of cancer, and four reviews [1, 2, 21, 34] concluded
a lack of statistically signiﬁcant association or presented con-
troversial ﬁndings. We identiﬁed main sources of observed
inconsistencies in many articles being the subject of analyses
including lack of an adjustment for fully established risk fac-
tors for particular types of cancer. For certain cancers, adjust-
ment for lifestyle factors such as smoking, alcohol
consumption, physical activity, body mass index, and family
history of cancer disease in the regression models is essential
for the proper evaluation of a risk.
We analyzed 26 observational cohort and case-control
studies on diﬀerent speciﬁc cancer sites and diﬀerent psy-
chosocial factors. We found authors analyzed associations
between PS and cancer using diﬀerent outcome measures,
follow-up periods, countries, sample sizes, gender classiﬁ-
cations, and controls for confounding factors. Of the 26
prospective cohort and case-control studies on the PS-
cancer association, 10 studies included only data for BC
(see Table 1). Seven of the 10 studies had a statistically
signiﬁcant risk increases when considering severe life
events alone or combined with risky lifestyle behavior,
anxiety, depression, insuﬃcient social support perception,
or avoidance strategy. The reported magnitude of the asso-
ciations between stressors and BC were signiﬁcant, e.g.,
OR = 1:76 for major events or OR = 5:66 for experience
of several stressors [29]. Three of the 10 studies concluded
severe life events [27, 30] or personality (e.g., decisiveness,
perceived value of life) [26] do not play an important role
in the BC etiology. Rather, the net sum of the evidence on
the enhancing eﬀect of severe life events on BC (seven of
the 10 papers, 70%) remains in accordance with the ﬁnd-
ings of the abovementioned review papers.
Considering associations between stressful life events
(death of loved ones, parents, spouse; daily life stress; marital
separation; and self-containing suﬀering), depression, and
speciﬁc types of cancer, all research articles noted increased
risk factors, although one study [44] observed an increased
risk among individuals with new depressive symptoms only
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and other authors [49] found an increase in the risk for
stressful events in past 5 years (see Table 2). In addition,
one study [36] reported increased mortality rates for self-
perceived stress linked with poor health outcomes, ﬁnancial
troubles, occupational problems, or consequences of per-
ceived stress for mortality, and the second study [41] found
worse treatment adherence for all stages of gastric cancer in
patients with psychological distress due to cancer diagnosis
and treatment. These ﬁndings are in contrast to the reviews
and meta-analyses analyzed in this overview that concluded
no relationships. Regarding the impact of mental disorders
and cancer risk and their interaction, the study by O’Neill
et al. [43] reported an increased overall cancer risk at diﬀer-
ent life stages and its dependence on a number of disorders
increased cancer risk even 2.3-times was found for more than
ﬁve disorders; the magnitude of the association was also gen-
der dependent. This study was based on self-reported diag-
nosis of cancer in 19 countries, including lifetime history of
16 diﬀerent DSM disorders of each the eﬀect was analyzed.
However, their identiﬁcation was based on respective recall
as well as the data on cancer disease were self-reported. In
addition, the risks were estimated for overall cancer but not
for its speciﬁc subtypes. Thus, the relative strong positive
relationships on the mental disorder-cancer outcome may
suﬀer from bias. Notwithstanding, a large sample size and
signiﬁcant high magnitudes of the associations (1.3-2.3) sug-
gest this study presents new information about the associa-
tion between mind and cancer.
Six studies included separate risk estimates for the associ-
ation between work place stress and speciﬁc types of cancer
[25, 34, 40, 42, 47, 48], three of these studies found increased
risk for prostate cancer [25, 42, 47] and one for lung, colon,
bladder, rectal, and stomach cancers [40]. The remaining
two studies found no eﬀect of workplace stress on brain risk
[34] and the hormone-related, virus immune-related, lung,
and digestive cancers [48]. Thus, the signiﬁcant cancer risk
increases related to work were observed in 66.7% of retrieved
observational studies.
Stress timing, time windows of stress exposure, stress
type, methodological diﬀerences in the measurement of
PS type, and individual’s stress susceptibility are poten-
tially important factors in a proper evaluation of the PS-
cancer risk association. Variation in the applied scale to
measure the same stressful life events presents as an
important problem. Use of diﬀerent PS test scales for a
measure of subjective stress and subtype of cancer in the
original papers, being the subject of this analysis, could
lead to diversity and inﬂuence the magnitude and power
of the relationships reported here. Continuing, this review
shows most studies controlled for confounding factors, but
only to some extent. An important issue when considering
confounding factors is the role of the main risk factors for
speciﬁc types of cancer, e.g., BC factors are linked with
reproductive status, lifestyle, anthropometric characteris-
tics, menopausal status, and ethnicity [51]. For example,
body mass index and physical activity could attenuate risk
estimates and inﬂuence on catecholamine levels in the
blood, consequently on levels of O2
⋅− and other ROS/RNS
toxic species [52]. However, it is important to note that in
our review period, the majority of research studies exam-
ined speciﬁc cancer types other than BC.
Several biochemical processes are considered in the PS-
cancer and PS-aging links including the activation of the
hypothalamic pituitary adrenal (HPA) axis, deregulation of
the sympathetic nervous signaling (SNS), inﬂammation,
and decrease in cellular immunity [4–6, 8, 11, 20, 53–61]
(Figure 2).
The HPA axis and SNS reportedly play an important role
in all stages of cancer: initiation, growth, and progression
[55]. During stress conditions, the HPA axis is activated,
followed by signaling, generation, and release of adrenocorti-
cotropic hormone which stimulates the adrenal gland to
release CATs (adrenaline, noradrenaline). Also, other stress
mediators like glucocorticoids (e.g., cortisol) participate in
tumor growth and metastasis [6, 54, 56]. Cortisol arises from
cholesterol and is released in response to stress and glucose
from the adrenal gland acting as enhancers and suppressors
of the immune system [56]. In turn, the SNS stimulates secre-
tion of noradrenaline in the blood stream [54]. The excess
CATs can aﬀect cancer progression, regulating several cellu-
lar signaling pathways through adrenergic receptors (ADRs)
of which expression was found in several cancer cells [6, 57].
ADRs act as enhancers of cancer cell proliferation and mod-
ulators of cancer cell interaction with their microenviron-
ment to promote tumor progression. Under severe stress
conditions, CATs activate β-adrenergic receptors on tumor
cells and enhance expression of matrix metalloproteinases
(MMPs) and vascular endothelial growth factor (VEGF) in
adipose tissue, forming new blood vessels [55]. They also
induce cell growth via promotion of cell cycle progression
and prevention of apoptosis. The β-ADR stimulates adenylyl
cyclase activity, an enzyme that catalyzes the conversion of
ATP to cAMP, followed by protein kinase A (PKA) activa-
tion. The β-ADR/cAMP/PKA signal cascade can induce
DNA damage or regulate expression of genes via activation
of transcription factors [57, 59]. Also, elevated levels of CATs
directly suppress the cell-mediated immunity acting as
reducing agents of macrophages and T-helper lymphocytes
(called Th cells) of cytokine producers (among other IL-12,
TNF-α, and IFN-γ) and indirectly by stimulation of the
immunosuppressive factor release, e.g., IL-10 and IGF-α [6,
56, 60]. Evidence has shown that cellular immune response
during carcinogenesis is complex and multidirectional with
anti- or proinﬂammatory activities depending on the tissue-
speciﬁc microenvironmental stimuli [56]. There is strong
evidence that chronic PS acts to suppress the natural killer
(NK) cell activity and immune system power during cancer
growth, progression, and metastasis [20, 62, 63]. The
immune dysfunction accompanying PS, caused by the
decreased production of antibodies, macrophages, mono-
cytes, and T cells and inhibition of NK cells’ activity play a
key role in carcinogenesis. Evidence has shown that chronic
inﬂammation occurs in several types of cancer. Morbidity
and mortality were found to be correlated with proteins
induced by PS such as IL-6 [3]. Also, immune cells such as
cytotoxic T cells and NK cells were detected in invasive and
metastatic tumors [20, 61]. Evidence on biological mecha-
nisms potentially explaining increased cancer risk among
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individuals with depression suggests a direct eﬀect on the
immune system through the HPA axis as well as an indirect
eﬀect through unhealthy lifestyle, e.g., tobacco smoking, alco-
hol consumption, low physical activity—behaviors which are
recognized as risk factors for some cancer subtypes [63, 64].
Alterations in key neurotransmitters were reported as
important contributors to the increased level of reactive oxy-
gen species (ROS) due to CATs’ oxidation among other ROS
sources [65]. As mentioned above, PS directly triggers the
release of CATs and glucocorticoids, thus aﬀecting the
immune system. Activated inﬂammatory cells are known
generators of ROS and reactive nitrogen species (RNS)
involved in DNA damage and genomic instability [66–69].
ROS/RNS are generated in cells by biological processes
(mitochondrial electron transport chain, NAD(P)H oxidase
(Nox), and response to cytokine and growth factor receptors)
and some metabolic enzymes as side products (so-called
endogenous sources) [70]. The second kind of ROS genera-
tion source exogenous includes physical and chemical factors
such as ultraviolet light, ionizing radiation, pollutants, path-
ogens, medicaments, chemotherapy, and lifestyle [67, 68].
Examples of ROS and RNS include superoxide anion radical
(O2
⋅−), hydroxyl radical (HO⋅), hydroperoxyl radical (HO2
⋅),
alkoxyl radical (RO⋅), peroxyl radical (ROO⋅), hydrogen per-
oxide (H2O2), singlet oxygen (
1O2), nitric oxide (NO
⋅), and
peroxynitrite (ONOO−) [69]. Evidence shows NAD(P)H oxi-
dase complexes as generators of ROS “have speciﬁc subcellu-
lar localization” producing these species in speciﬁc cellular
compartments [71]. In study on human cell line MOLM-13
(acute myeloid leukemia), Guida et al. [71] reported that 1,
2, and 4 isoforms of NOx (Nox1, Nox2, Nox4, respectively),
p22phox, and Rac1 gene subunits were expressed in cell lines
of myelodysplastic syndrome/acute myeloid leukemia sam-
ples with damaged DNA in the nuclear fractions. The authors
also found that Nox4 isoform was localized in the nucleus
and inhibition of the isoform activity was followed by
decreased formation of nuclear ROS in the nucleus. Further,
the authors maintain that Nox4 isoform can participate in
the regulation of information transfer from DNA to a mes-
senger RNA (mRNA) due to ROS formation in the speciﬁc
nuclear domains. In addition, it has been reported that
Nox4 interacts with the Akt and ERK (extracellular signal-
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Figure 2: Simpliﬁed hypothetical scheme for the role of psychological stress in carcinogenesis and aging. CATs: catecholamines; ROS:
reactive oxygen species; O2
⋅−: superoxide anion radical; HO⋅: hydroxyl radical; H2O2: hydroxyl peroxide;
1O2: singlet oxygen; NO
⋅: nitric
oxide; ONOO−: peroxynitrite; HPA axis: hypothalamic pituitary adrenal axis; SNS: sympathetic nervous signaling.
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regulated kinase) signal transduction pathways. Based on
available information, many transcription factors, for exam-
ple, nuclear factor-κB (NF-κB), activator protein 1 (AP-
1), a basic tumor suppressor gene (p53), NF-E2-related
factor (Nrf2), and hypoxia-inducible factor-1α (HIF-1α),
exhibit the redox sensitivity; the formation of ROS in the
nucleus linked with Nox4 activity inﬂuences the nucleus
redox homeostasis, thus regulating transcription of the
redox-sensitive factors, gene expression and regulation,
aﬀecting cell growth, diﬀerentiation, senescence, and apo-
ptosis [71, 72]. Findings on the role of Nox4 in nuclear
ROS production highlight the molecular mechanisms (at
the level of the cell nucleus) responsible for genomic insta-
bility in myelodysplastic syndromes [73]. The knowledge of
OS regulation in cells is important in both the cancer devel-
opment and anticancer therapies [74].
Evidence has shown the carcinogenesis process is charac-
terized by hypoxia and inﬂammation [75–79]. Metabolism of
normal cells undergoes change during their transformation
to cancer cells, i.e., the phospholipid peroxidation pathway
is shifted towards fermentative glycolysis, a process known
in the subject literature as “Wartburg eﬀect” or the Myc/hy-
poxia-induced metabolic pathway [80, 81]. This process
results from the uncontrolled growth signaling, deregulation
of the family of regulator genes and protooncogenes (c-Myc),
and hypoxia-inducible factor 1 (HIF-1) activities. In this way,
the glycolytic enzymes are induced, and the ﬁnal product of
glycolysis pyruvate in mitochondria is reduced [82]. In
tumors, oncogenes and tumor suppressor agents activate
mitogenic pathways such as Ras-Raf-ERK (extracellular-sig-
nal-regulated kinase) and P13K- (phosphatidylinositol 3-
kinase-) AKT (protein kinase B) pathways which promote
glucose metabolism; cell growth, proliferation, and survival;
and apoptosis [81]. In cancer cells, these pathways are acti-
vated by Myc and HIF-1 promoting metabolism and accu-
mulation of its products. Thus, cancer cells can respond to
a stressor, i.e., OS via increased activation transcription factor
(ATF)-4 [83] and nuclear factor erythroid 2-related factor
(Nrf2), a transcription activator responding to ROS and elec-
trophile generation and promote their detoxiﬁcation being
procarcinogenic in neoplasia expression [84]. Recently, the
current state of knowledge on “Wartburg eﬀect” and experi-
mental data on the glycolysis genetic disruption and novel
cell death mechanisms, based on the responses of cancer cell
lines, with potential utility for anticancer strategy, have been
reported by Ždralević et al. [81]. The authors showed that, in
contrast to normal cells which derive their energy from respi-
ration, the suppression of “Wartburg eﬀect” has little eﬀect
on proliferation of cancer cells and tumor growth because
of eﬃcient reactivation of respiration as a source of energy
and increased redox status. As cancer cells in this state are
strongly susceptible to glutathione depletion [85], and cystei-
ne/glutamate antiporter xCT controls glutathione synthesis
and Nrf2 contributes to respiratory re-activation, Ždralević
et al. proposed a mechanism of cancer cell death called “fer-
roptosis” as a new target for cancer therapy, i.e., an inhibition
of xCT antiporter; this allows for the use of the acute lethal
peroxidation of phospholipid to cause the death of aggressive
cancer cells [81].
Among the major cellular growth- and proliferation-
linked signal transduction pathways involved in responding
to OS is the mitogen-activated protein kinase (MAPK) cas-
cade. Cells' response to stress involves several mechanisms
ranging from the stimulation of pathways promoting survival
to the initiation of cell death and possible elimination of
damaged cells; this process depends on the type of cell as well
as the nature and duration of the stress [86]. In the last two
decades, the apoptosis signal-regulating kinase (ASK) family
members ASK1, ASK2 and ASK3, the key molecules in
MAPK signal cascade, have attracted much attention. ASK1
participates in the regulation of cell survival, proliferation,
inﬂammation, and apoptosis [87]. Evidence has shown that
ASK1 in response to OS and the bacterial component lipo-
polysaccharide (LPS) activates c-Jun N-terminal kinase
(JNK) and p38 kinase which are involved in apoptosis and
inﬂammation in response to stressful stimuli, where ROS
are the stress mediators and control many cellular processes
[87, 88]. The ﬁnding of Matsuzawa showed that the ASK1-
p38 signaling pathway is critical for the formation of inﬂam-
matory cytokines (TNF-α, IL-6, IL-12, and IL-1β); these
ﬁnding demonstrate ASK1 signaling is involved in mamma-
lian innate immunity [88]. Importantly, ASK1 activation is
regulated by thioredoxin (Trx), an antioxidant that in a
reduced form contains two thiol (SH) groups playing the
basic role in the regulation of redox signaling [89]. In an inac-
tive state, ASK1 forms inactive molecular complex with
reduced Trx. Under conditions of OS, the reduced form of
Trx undergoes oxidation followed by the complex dissocia-
tion, leading to the conversion of OS signal to a
phosphorylation-dependent signal; thus, Trx acts as an eﬃ-
cient antioxidant. Further, the recruitment of the tumor
necrosis factor-α receptor-associated factors (TRAFs) 2 and
6 activate an inactivate ASK1 molecule to its active form.
Matsuzawa underlines that activation of the TRAF6-ASK1-
p38 pathway dependent on ROS level is needed for the
generation of cytokines and phagocytosis during the innate
immune system response to stress. Research ﬁndings have
shown that ASK1-p38 signaling induces various immune
diseases such as multiple sclerosis, rheumatoid arthritis,
and cardiovascular and various infectious diseases. For
the comprehensive reviews and extensive discussion on
innate immune system response to stress, References [87,
88, 90] are illustrative.
The next important consequence of excess ROS is aging,
the process which touches all living organisms. There is
abundant research conﬁrming association between severe
OS stress and elevated risk of age-related diseases. Aging is
considered the universal multifactorial and progressive pro-
cess accompanied by loss of tissue and organ function over
time [91–93]. Among many theories of aging are the free rad-
ical theory and mitochondrial theory [92, 94, 95]; both theo-
ries hypothesize that ROS are one of the main reasons of
aging. According to the free radical hypothesis of aging, this
process is caused by the accumulation of oxidation products
of lipids and proteins and structural damages in mitochon-
drial DNA, RNA molecules by ROS, and RNS. In addition,
cellular antioxidant systems are weakened, and the intracel-
lular level of ROS is increased due to increased rate of
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formation. The aging process can be associated with muta-
tions and neoplastic transformation [68, 96]. Several tran-
scription factors are modulated by ROS, e.g., NF-κB, AP-1,
Nrf2, p53, hypoxia-inducible factor-1α (HIF-1α), signal
transducer, and activator of transcription 3 (STAT 3) [68].
It is maintained that ROS participates in the initiation
and progression of cell aging, and their accumulation can
cause OS followed by mRNA damage, a decrease in mito-
chondrial function, and progression of age-related diseases
(i.e., arthritis, diabetes, vascular diseases, dementia, and can-
cer) [77, 97]. (For a detailed review on the role of OS in aging
and age-related diseases, see reviews of Liguori et al. [92] and
Davalli et al. [95].) Further, the aging process is characterized
by chronic low-grade systemic inﬂammation caused by lim-
ited elimination of damaged cells and biomolecules [96].
The decreasing potency of endogenous antioxidant sys-
tems with growing age increases susceptibility of cell and tis-
sues to OS [98]. Evidence shows transcriptional activities of
IL-1β, IL-6, TNF-α, cyclooxygenase-2 (COX-2), nitric oxide
synthase (iNOS), and several other proinﬂammatory pro-
teins are increased during aging. Further, aging is also char-
acterized by the increased number of monocytes and
neutrophils, and C-reactive protein (CRP) levels. In turn,
more recent evidence has also shown that depletion of Nrf2
activity is involved in the development of age-related diseases
[99]. For additional review, see [98]. Comprehensive experi-
mental studies over the past decade have shown OS can
impair stem cells’ redox homeostasis in hematopoietic, neu-
ral, and muscle stem cell compartments [100]. Stem cells
are involved in preserving tissue homeostasis and the repair
of damaged DNA through replacing damaged/lost cells; thus,
they play an important role for functional tissue and organ
maintenance [101]. Therefore, the regulation of balance
between quiescence, self-renewal, and diﬀerentiation is cru-
cial for stem cell functioning during early development and
cell homeostasis [100–102]. The cellular changes linked with
aging (called cellular senescence) may lead to irreversible
arrest of cell growth and changes in the cellular phenotype
owing to the impaired signaling [103].
The response mechanism of stem cells on OS is not well
recognized, but accelerated telomere shortening, increased
double-stranded DNA breaks, and nuclear A-type prelamin
accumulation, followed by stem cell senescence or premature
aging and cell death, have been reported [103]. An important
role of A-type prelamins, i.e., the proteins responsible for the
structural and functional integrity of the cell nucleus, is the
ability to modulate intracellular redox homeostasis [101].
The experimental study of aging processes during in vitro
expansion of stem cells from amniotic ﬂuids (hAFSCs cul-
tures) by Casciaro et al. showed low levels of intracellular
ROS prevented nuclear A-type prelamin accumulation and
Nox4 nuclear activity towards ROS production [101]. This
ﬁnding supports a key role of OS in the cellular aging process.
In addition, Porto et al. explored the role of ROS in bone
marrow hematopoietic stem cell (HSC) aging ﬁnding the
aged mice cells (24 month aged) had increased intracellular
concentrations of the following compounds: O2
⋅− (1.4-fold),
H2O2 (2-fold), and NO (1.6-fold), peroxynitrite/OH
⋅ (2.5-
fold) comparing with young mice cells (2 months old)
[104]. Moreover, the authors observed a 3.3.-fold increase
in the number of HSCs during the lifetime of aged mice
comparing with the cell number of young mouse cells
and found a positive correlation between cell aging and
age of mice: 12-month-old mice had a 4.2-fold increase
in DNA damage and a 2-fold in apoptosis, while 24-
month-old mice 6-fold and 4-fold increases, respectively.
In addition, the older mice had a shorter telomere length
compared with the middle-aged mice.
Due to the repair property of stem cells and their
potential application as promising drug targets for several
pathology in regenerative medicine, the current research
has focused on the role of Nox isoforms in stem cell diﬀer-
entiation, renewal, and cancer stem cell growth and survival
[105, 106] and Nox inhibitors to regulate OS in stem cells
[102, 107]. Until now, evidence showed Nox isoforms play
a leading role in all the abovementioned processes. Several
of the seven isoforms participate in each process, Nox4
plays a crucial role in O2
⋅− and H2O2 generation, and the
Nox2 and Nox4 activities were found to be increased in
majority of stem cell types [105]. There are also reports that
proliferation of some solid cancers and their resistance to
chemotherapy are dependent on tumor-initiating cells of
cancer stem cells; the cells exhibit the self-renewal ability
and potency to develop tumor and metastasis [106].
Although the pathologically altered expression and activity
of stem cells in response to OS are linked with several
inﬂammatory diseases including the development of several
types of cancers (e.g., lung, colon, and prostate) and their
progression, the mechanisms of Nox-formed ROS in carci-
nogenesis are not fully understood.
A number of studies indicated that an excess of ROS/RNS
followed by OS, i.e., a disturbance of equilibrium between
prooxidant processes and the protective strategies of antiox-
idant defense system, is genotoxic and can induce DNA dam-
age; thus, they may play a key role in cancer development and
progression [75, 77, 78] and in neuropsychiatric disorders,
such as schizophrenia or depression [108]. Excess intracellu-
lar ROS may result in neuronal membrane damage, alter a
broad range of its functions, and cause multineurotransmit-
ters’ pathologies [69].
Long-lasting permanent stress can lead to upregulation of
the signal transduction in cancer cells and the tumor envi-
ronment followed by tumor growth and progression [109].
Shin et al. [6] suggested individuals who experienced long-
lasting permanent stress can accumulate cellular damage
followed by their transformation into cancer cells. Interest-
ingly, there is evidence that women who experience trau-
matic stress have shortened telomeres becoming 10 years
older compared to low-stress women [110, 111]. This means
the region of repetitive DNA of a chromosome is less pro-
tected from deterioration. Accelerated rate of telomeres’ deg-
radation is associated not only with aging but may also lead
to oncogenesis of somatic cells [112]. The implications of
OS and other biological processes, such as accumulation of
DNA damage, telomere shortening, elevated levels of proin-
ﬂammatory cytokines, impaired immune system, inﬂamma-
tion, and deregulated levels of stress hormones, are
suggested to occur in the psychological disorders and in
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cancer diseases [16, 18]. OS has been shown to play an
important role in tumor initiation, promotion, and progres-
sion [67, 68] and is implicated in the pathogenesis of various
biological systems and organs (reviewed lately by Kruk et al.
[77]). The role of PS in increased DNA damage has been sup-
ported by human studies, in vitro studies with animals, and
cell lines exposed to stress hormones [14, 59, 113]. These
multivariate complexities show the diﬃculty in determining
and expressing the association between PS and cancer risk.
4.1. Limitations. There are several limitations in this review.
First, our conclusions are based to a large extent of reviewed
studies on case-control, 11 of 26 observational studies, where
selection bias, recall bias, and detection bias are common.
Individuals with cancer could have a higher level of PS per-
ception as a factor for cancer than healthy individuals, thus,
leading to the over-reporting of stress exposure. Second,
selection of information from retrieved articles might be sub-
jective and also lead to bias. In order to minimize potential
selection bias, two research staﬀ members independently
selected articles for inclusion. Third, we analyzed only studies
that met our inclusion criteria and excluded other studies.
Finally, we included only articles in English in this overview.
5. Conclusions
The result of this overview demonstrates that review studies
diﬀer in their assessment of the contribution of behavioral
factors such as chronic stress, severe life events, and person-
ality to onset of cancer. The research evidence points to a
prominent role for chronic daily life event stress, severe life
events, depression, and social isolation in cancer growth
and metastasis. Results from recently published observa-
tional epidemiologic studies, being the main subject of this
review, have continued to establish an evidence base suggest-
ing psychosocial factors may be risk factors for speciﬁc types
of cancer incidence. In addition, recent evidence on psycho-
social stress, including job stress, and speciﬁc types of cancer
other than BC association is stronger than previously sug-
gested in the literature. This conﬁrms the conclusion of an
important role for chronic stress in aging, development of
cancer, and cancer growth and metastasis, based on previous
studies analyzed in the review papers. However, several dis-
crepancies were found in the literature, which include meth-
odological diﬀerences in the measurements of PS type,
timing, limited number of prospective studies, small sample
sizes, and a lack of adjustments for the main risk factors for
speciﬁc types of cancer and lifestyle factors. The eﬀect of
chronic PS on carcinogenesis has a plausible biological ratio-
nale. The body of evidence indicates unregulated release of
CATs (adrenaline, noradrenaline) by the activation of HPA
axis, deregulation of SNS, and adrenal glands in response to
PS increases the generation of proinﬂammatory proteins
and disturbs cell homeostasis involving OS along with a
decrease in cellular immunity. Evidence shows the important
role of Nox isoform inhibitors in regulation of OS in stem
cells particularly ASK1 in innate immune signaling,
highlighting their importance in the cellular aging and
cancer. As understanding these processes grow, there is
hope they may oﬀer new clues for therapeutic approaches
in treating cancer. Our ﬁndings may become a greater part
of health prevention strategy associated with modiﬁable
behavioral factors, e.g., work conditions or coping with
self-perceived stress. Finally, this article may inspire or
guide future studies on the PS-cancer risk association of
high methodological quality.
5.1. Future Perspectives. Determining the causal relationship
between PS and cancer risk requires large-scale research
eﬀorts involving participation from multidisciplinary health
specialists. This is due to the multivariate complexities asso-
ciated with sources of PS, the relationship between stress
and cancer disease, and the complicated nature of modiﬁable
behaviors. Future epidemiological observational studies
require larger study populations, international collaboration,
unselected patient groups, and questionnaires providing
detailed behavioral information to assess possible risk factors
for particular cancer types considered as potential con-
founders. In addition, future studies should provide a signif-
icant measure of PS regarding the type and duration using
valid and reliable scales to ensure a clear dose-response rela-
tionship. This approach could clarify existing biological
mechanisms and identify additional risk pathways including
ROS-induced associated with the relationship between PS
and particular cancer types’ outcome as well as the role of
ROS/RNS in aging.
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